Real World Evidence. Real Results.
Discover technology-enabled approaches to generate cost-effective evidence at scale
Real world evidence (RWE) is increasingly being used across the product lifecycle, shaping trial strategy and design, influencing regulatory decision making, and demonstrating commercial differentiation and drug value. Join our upcoming series to discover more about how you can:
- Maximise value from RWE generation with an Integrated Evidence Strategy that supports end-to-end, multi-stakeholder needs
- Incorporate patient centricity as a true strategic catalyst
- Leverage the latest technologies and direct-to-patient innovations to enable faster, more efficient evidence generation for real world studies
- Discover how technology-enabled analytics, natural language processing, and AI/ML can better inform decision making
Session 3 title: Unlocking the value of real world data with NLP and AI
- Learn how AI-powered approaches can enable faster decisions and optimize success from R&D through to commercial launch activities.
- Discover untapped value in unstructured text through NLP to generate rich insights and enable well-informed decisions.